Ignite Creation Date:
2025-12-26 @ 10:17 PM
Ignite Modification Date:
2026-03-09 @ 10:32 AM
Study NCT ID:
NCT06805812
Status:
RECRUITING
Last Update Posted:
2025-02-03
First Post:
2025-01-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Predicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advanced Hormone REceptor-poSitive HER2-negative Breast Cancer: the Retrospective-prospective Multicenter Italian PALMARES-2 Study
Sponsor:
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Breast Adenocarcinoma | View |
| None | Breast Cancer Stage IV | View |
| None | Breast Cancer, Metastatic | View |
| None | Breast Carcinoma | View |
| None | Breast Diseases | View |
| None | Breast Neoplasms | View |
| None | Breast Neoplasms, Male | View |
| None | Breast Cancer | View |
| None | Breast Cancer With Metastatic Bone Disease | View |
| None | Breast Cancers | View |
| None | Breast Neoplasm | View |
| None | Breast Tumors | View |
| None | HR+ HER2- Men, Pre/Postmenopausal Advanced Breast Cancer | View |
| None | HR+ Advanced or Metastatic Breast Cancer | View |
| None | HR+/HER2- Breast Cancer | View |
| None | HRpos Breast Neoplasms | View |
| None | HR-positive, HER2-negative Advanced Breast Cancer | View |
| None | HR-positive, HER2-negative and PIK3CA Mutation Advanced Breast Cancer | View |
| None | HR-positive Breast Cancer | View |
| None | Hormone Receptor-Positive Breast Cancer | View |
| None | Hormone Receptor Positive Breast Adenocarcinoma | View |
| None | Hormone Receptor Positive Breast Carcinoma | View |
| None | Hormone Receptor Positive Breast Neoplasms | View |
| None | Hormone Receptor Positive HER-2 Negative Breast Cancer | View |
| None | Hormone Receptor Positive Malignant Neoplasm of Breast | View |
| None | Hormone Receptor Positive Metastatic Breast Cancer | View |
| None | Hormone Receptor Positive, HER2 Negative Breast Cancer | View |
| None | Hormone Receptor Negative Breast Cancer | View |
| None | Hormone Receptor Positive, HER2-negative, Advanced Breast Cancer | View |
| None | Hormone Receptor Positive Breast Cancer | View |
| None | Hormone Receptor Positive (ER+/PR+, and Her2-) Metastatic Breast Cancer | View |
| None | Hormone Receptor Positive, HER2-negative Neoplasms | View |
| None | Hormone Receptor Positive, HER2-low Neoplasms | View |
| None | Hormone Receptor Positive (HR+), HER2-negative Breast Cancer | View |
| None | Hormone Receptor (HR)-Positive Breast Cancer | View |
| None | Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer | View |
| None | Palbociclib | View |
| None | Ribociclib | View |
| None | Abemaciclib | View |
| None | CDK4/6 Inhibitor | View |
| None | CDK4/6 Inhibitors | View |
Keywords: